Sundaram Preethi
- SEC CIK
- 0001872422
No open-market purchases or sales filed in the past year.
Current role at each company
- CPRX Catalyst Pharmaceuticals, Inc.Chief Strategy Officeras of Jul 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sundaram Preethi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 (view filing) | Jun 10-11 | 2 days | Sundaram PreethiChief Strategy Officer | SSaleCommon Stock, par value $0.001 per share | −3.92K | $26.41 | −$103.6K | −8.7%41.1K after | 2 lots |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Sundaram PreethiChief Strategy Officer | SSaleCommon stock, par value $0.001 per share | −56.8K | $16.38 | −$929.9K | −100.0%0 after | 2 lots |
| Sep 16, 2022 (view filing) | Sep 15 | 1 day | Sundaram PreethiChief Strategy Officer | SSaleCommon stock, par value $0.001 per share | −18.2K | $14.49 | −$263.9K | −100.0%0 after |